+15.3%
ENTG vs BBIO
+42.7%
-27.4%
-59.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.2% | -0.1% | +2.2% | +2.2% |
| 7D | +1.2% | -3.2% | +4.4% | +1.7% |
| 30D | -12.9% | -13.6% | +0.7% | -11.0% |
| 3M | -3.1% | +7.2% | -10.3% | -4.2% |
| 6M | +21.0% | +1.5% | +19.5% | +20.5% |
| YTD | +67.0% | -5.3% | +72.3% | +67.2% |
| 1Y | +68.6% | +37.7% | +30.9% | +59.6% |
| 3Y | +48.6% | +153.9% | -105.3% | +26.4% |
| All | +15.3% | +42.7% | -27.4% | -24.0% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling